隔离和描述了一种感染Enterococcus faecium的新型菌体vB_Efm_LG62
Qianyu Qu1, Tao Chen2, Penggang He1
1West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, China.
Virus genes
|July 9, 2023
概括
研究人员分离出了一种新型细菌菌体,vB_Efm_LG62,有效对抗多药耐药的Enterococcus faecium. 这一发现为对抗高优先病原体感染和推进菌体治疗策略提供了一个有希望的新工具.
科学领域:
- 微生物学 微生物学
- 病毒学 病毒学
- 传染性疾病 传染性疾病
背景情况:
- 菌 (Enterococcus faecium) 是一个高优先级的病原体,导致全球性医院感染.
- 增加E. faecium的抗生素耐药性需要使用替代治疗策略.
- 菌体疗法是对抗多药耐药细菌的一种有希望的方法.
研究的目的:
- 为了隔离和表征一种针对多药耐药的新型毒性细菌菌体Enterococcus faecium.
- 评估隔离的菌体治疗E. faecium感染的治疗潜力.
主要方法:
- 分离和表征菌体 vB_Efm_LG62.2.
- 形态分析和确定感染的最佳多重性.
- 一步增长曲线分析以确定潜伏期和爆发大小.
- 全基因组测序,以分析菌体的遗传构成并识别功能基因.
主要成果:
- 一种新的类似细菌病毒的细菌,vB_Efm_LG62,被分离和鉴定.
- 体vB_Efm_LG62证明了对多药耐药E. faecium.的有效感染.
- 基因组测序揭示了42236bp的双链DNA基因组与66个预测的编码序列,缺乏毒性或抗生素耐药性基因.
- 感染的最佳多重性为0.001,潜伏期为20分钟,爆发大小为101个PFU/细胞.
结论:
- 体vB_Efm_LG62是一种高效,毒性细菌体,具有针对多药耐药E. faecium的显著治疗潜力.
- 在vB_Efm_LG62中缺乏毒性和抗生素耐药性基因,提高了其治疗应用的安全性.
- 这项研究扩大了对E. faecium向菌体的知识,并有助于开发基于菌体的疗法,包括菌体尾酒配方.
相关概念视频
Viral Replication: Lytic Cycle
87
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
87
Lytic Cycle of Bacteriophages
71.0K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
71.0K
Viral Replication: Lysogenic Cycle
84
The lysogenic cycle is a crucial viral replication strategy that allows bacteriophages to persist within host cells without immediately destroying them. This process is primarily observed in temperate phages, such as bacteriophage lambda (λ), which infects Escherichia coli. The cycle allows the viral genome to persist across bacterial generations while keeping host cells viable.Integration of the Viral GenomeUpon infection, bacteriophage lambda attaches to the bacterial surface and injects...
84
Lysogenic Cycle of Bacteriophages
62.4K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
62.4K
DNA Bacteriophages
61
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
61


